Search

Search any products, services and so on here.

About 14712 result(s)

Global Prefilled Methotrexate Injection Market Research Report 2024

  • Aug 28, 24
  • ID: 514024
  • Pages: 77
  • Figures: 68
  • Views: 2
  • From $2,900

Prefilled methotrexate injection is a preparation of methotrexate, which is prefilled and easy for patients to use. As a folic acid antagonist, methotrexate has a broad spectrum of anti-tumor activity and can be used alone or in combination with other chemotherapy drugs to treat a variety of malignant tumors and immune diseases. The global Prefilled Methotrexate Injection market was valued at US$...


Global Brigatinib API Market Research Report 2024

  • Aug 28, 24
  • ID: 513999
  • Pages: 95
  • Figures: 96
  • Views: 4
  • From $2,900

Brigatinib is an active pharmaceutical ingredient (API) used for the treatment of non-small cell lung cancer (NSCLC) with ALK gene mutations.It is a selective ALK inhibitor that works by blocking the ALK protein. The global Brigatinib API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030. North Ameri...


Global Ceritinib API Market Research Report 2024

  • Aug 28, 24
  • ID: 513998
  • Pages: 95
  • Figures: 96
  • Views: 4
  • From $2,900

Ceritinib is an active pharmaceutical ingredient (API) used as a targeted therapy for treating non-small cell lung cancer (NSCLC) with ALK gene rearrangements.It functions as a potent and selective ALK inhibitor,blocking the activity of the ALK protein,which is implicated in the growth and survival of cancer cells. The global Ceritinib API market was valued at US$ million in 2023 and is anticipate...


Global Crizotinib API Market Research Report 2024

  • Aug 28, 24
  • ID: 513997
  • Pages: 104
  • Figures: 102
  • Views: 4
  • From $2,900

Crizotinib is an active pharmaceutical ingredient (API) used as a targeted therapy for cancers with ALK gene alterations,primarily non-small cell lung cancer (NSCLC).It works by inhibiting the ALK protein, which is involved in tumor growth. The global Crizotinib API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast p...


Global ALK Inhibitors Market Research Report 2024

  • Aug 28, 24
  • ID: 513996
  • Pages: 83
  • Figures: 84
  • Views: 4
  • From $2,900

ALK inhibitors are a class of targeted cancer therapies designed to treat tumors with alterations in the ALK (anaplastic lymphoma kinase) gene.By specifically blocking the activity of the ALK protein,these inhibitors help to impede cancer cell growth and proliferation,which are primarily used in treating non-small cell lung cancer (NSCLC) that harbors ALK mutations or rearrangements. The global AL...


Global Magnesium Isoglycyrrhizinate API Market Research Report 2024

  • Aug 28, 24
  • ID: 513995
  • Pages: 71
  • Figures: 68
  • Views: 3
  • From $2,900

Magnesium Isoglycyrrhizinate is an active pharmaceutical ingredient (API) known for its anti-inflammatory and antioxidant properties,often used in skincare and dermatological treatments.It is a magnesium salt derived from glycyrrhizin,a compound found in licorice root,and is used to help manage skin conditions such as eczema and psoriasis. The global Magnesium Isoglycyrrhizinate API market was val...


Global Medicinal and Food Homologous Health Product Market Research Report 2024

  • Aug 28, 24
  • ID: 496120
  • Pages: 89
  • Figures: 202
  • Views: 3
  • From $2,900

The global Medicinal and Food Homologous Health Product market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Medicinal and Food Homologous Health Product is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of...


Global Voglibose Tablets Market Research Report 2024

  • Aug 28, 24
  • ID: 495981
  • Pages: 87
  • Figures: 208
  • Views: 3
  • From $2,900

The global Voglibose Tablets market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Voglibose Tablets is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030. Asia-Pacific market for Voglibose...


Global Lurasidone Hydrochloride Tablets Market Research Report 2024

  • Aug 28, 24
  • ID: 495979
  • Pages: 83
  • Figures: 171
  • Views: 3
  • From $2,900

Lurasidone hydrochloride tablet is an antipsychotic drug that exerts a sedative effect through combined antagonism of central dopamine and serotonin receptors. Mainly used for the treatment of schizophrenia. The global Lurasidone Hydrochloride Tablets market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-20...


Global Calcium Carbonate and Vitamin D3 Chewable Tablets Market Research Report 2024

  • Aug 28, 24
  • ID: 495978
  • Pages: 77
  • Figures: 182
  • Views: 2
  • From $2,900

Calcium Carbonate D3 Chewable Tablets,The main ingredient is calcium carbonate, and the excipients are usually sorbitol, PVPK30, orange flavor granules, aspartame and magnesium stearate. It is used to prevent and treat osteoporosis, and can also be used as a calcium supplement for pregnant women, lactating women, menopausal women, and the elderly. The global Calcium Carbonate and Vitamin D3 Chewa...


Our team would be happy to assist you with your queries.

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232